These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36043589)
1. Macroprolactin screening in 464 patients with hyperprolactinaemia. Lim MH; Ho CKM Malays J Pathol; 2022 Aug; 44(2):261-267. PubMed ID: 36043589 [TBL] [Abstract][Full Text] [Related]
2. Interference by macroprolactin in assays for prolactin: will the Fahie-Wilson MN; Cobbaert CM; Horvath AR; Smith TP Clin Chem Lab Med; 2022 Aug; 60(9):1350-1355. PubMed ID: 35704648 [TBL] [Abstract][Full Text] [Related]
3. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Fahie-Wilson MN; Soule SG Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821 [TBL] [Abstract][Full Text] [Related]
4. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay. Whitehead SJ; Cornes MP; Ford C; Gama R Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991 [TBL] [Abstract][Full Text] [Related]
5. Optimizing laboratory defined macroprolactin algorithm. Šostarić M; Bokulić A; Marijančević D; Zec I Biochem Med (Zagreb); 2019 Jun; 29(2):020706. PubMed ID: 31223260 [TBL] [Abstract][Full Text] [Related]
6. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Olukoga AO; Kane JW Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974 [TBL] [Abstract][Full Text] [Related]
7. Determination of prolactin: the macroprolactin problem. Fahie-Wilson M; Smith TP Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642 [TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity in assays for prolactin and optimum screening policy for macroprolactinaemia. Smith TP; Kelly S; Fahie-Wilson MN Clin Chem Lab Med; 2022 Aug; 60(9):1365-1372. PubMed ID: 35708266 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation. Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507 [TBL] [Abstract][Full Text] [Related]
11. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Hattori N; Ishihara T; Saiki Y Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017 [TBL] [Abstract][Full Text] [Related]
12. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'! Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204 [TBL] [Abstract][Full Text] [Related]
13. Patients with macroprolactinaemia: clinical and radiological features. Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206 [TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological features of patients with macroprolactinaemia. Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157 [TBL] [Abstract][Full Text] [Related]
15. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins. Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912 [TBL] [Abstract][Full Text] [Related]
16. Should macroprolactin be measured in all hyperprolactinaemic sera? McKenna TJ Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649 [TBL] [Abstract][Full Text] [Related]
17. Macroprolactinaemia, the major unknown in the differential diagnosis of hyperprolactinaemia. Cattaneo F; Kappeler D; Müller B Swiss Med Wkly; 2001 Mar; 131(9-10):122-6. PubMed ID: 11416967 [TBL] [Abstract][Full Text] [Related]
18. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas. Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748 [TBL] [Abstract][Full Text] [Related]
19. The detection of macroprolactin by precipitation and ultrafiltration methods. Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220 [TBL] [Abstract][Full Text] [Related]
20. Importance of screening for macroprolactin in all hyperprolactinaemic sera. Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]